Position in SVRA
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$3,353,963
New position
Shares Held
614,279
first reported quarter
Ownership
0.300%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#44
of 184 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 32.63256598386076.ToString("F0")%
Shared 31.178666371469642.ToString("F0")%
None 36.1887676446696.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Moody Aldrich Partners LLC holds $96,976,320 across 28 Biotechnology names. SVRA ranks #12 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
21,688 | $6,987,656 | |
| 2 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
82,129 | $6,892,265 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
226,028 | $6,871,251 | |
| 4 | CRNX |
Crinetics Pharmaceuticals, Inc.
|
183,438 | $6,662,468 | |
| 5 | ORKA |
Oruka Therapeutics, Inc.
|
135,061 | $6,624,742 | |
| 6 | NKTR |
Nektar Therapeutics
|
89,527 | $6,441,467 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
33,973 | $5,742,116 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
53,893 | $5,680,322 |
All Filings in SVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,353,963 | 614,279 | Shares | Sole | 2026-04-20 | |
| No filing history on record for this holder in this stock. | ||||||